A Phase 2b Open-Label, Single Arm Study to Evaluate the Efficacy of Voxelotor for Improving Oxygen Saturation and Reducing Ventilatory Support Requirements in Adult Patients with New or Increased Oxygen Requirement.

Administered By

Awarded By

Contributors

Start/End

  • March 17, 2022 - February 24, 2024